Tirzepatide promotes weight loss by mimicking the effects of two hormones involved in appetite regulation, GLP-1 and GIP
Women who had taken a GLP-1 had a lower incidence of breast cancer than women who hadnt taken the medication, even after researchers matched for age, race, ethnicity, BMI, breast density, and type 2 diabetes
In June 2024, Bloomberg highlighted Okava Pharmaceuticals' efforts to develop an implantable device for administering GLP-1 drugs in cats
Clinical studies have shown that semaglutide, when combined with healthy lifestyle changes such as diet and exercise, can lead to significant and sustained weight loss
Outcomes were compared with placebo or non-placebo control groups
What happens after you stop depends on the habits you build while on the medication and whether you have professional support during the transition